IVA · Inventiva SA

2.74

EUR

-0.10 (-3.527%)

16/10/2026 12:00:00 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Euro674.69M

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 16/10/2026 12:00:00 AM

Price Chart

Description

Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.

All-Companies
All-Consensus
HALO 200
HALO All
HALO Consensus Value
HALO Earnings Momentum
HALO Growth
HALO Momentum
HALO Small
Hammer Bullish (Realtime)

Key Fundamentals

EPS 3 yr Growth

44.80%

EBITDA Margin

NaN%

Operating Cashflow

-€105m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

-4.00

Quick Ratio

3.20

Performance

52 weeks range

Low 2.57 - 6.2

Trade Value (12mth)

US$471,563.00

1 week

1.25%

1 month

-14.48%

YTD

-29.91%

1 year

-9.57%

All time high

16.30

Additional Data

Shares Outstanding (Fully Diluted)

274m

HALO Sector

Healthcare

Next Company Report Date

31-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

EUR

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Neutral

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

No announcements available.

Key Stakeholders

Name	Title
Invus Financial Advisors LLC	Private Company
Andera Partners SCA	Subsidiary
Eventide Asset Management LLC /Venture Capital/	Operating Division
Sofinnova Partners SAS	Private Company
NEA Management Co. LLC	Holding Company